These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10465542)
1. Design of peptides derived from anti-IgE antibody for allergic treatment. Takahashi M; Ohgitani Y; Ueno A; Mihara H Bioorg Med Chem Lett; 1999 Aug; 9(15):2185-8. PubMed ID: 10465542 [TBL] [Abstract][Full Text] [Related]
2. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Chang TW; Wu PC; Hsu CL; Hung AF Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539 [TBL] [Abstract][Full Text] [Related]
3. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. McDonnell JM; Beavil AJ; Mackay GA; Jameson BA; Korngold R; Gould HJ; Sutton BJ Nat Struct Biol; 1996 May; 3(5):419-26. PubMed ID: 8612071 [TBL] [Abstract][Full Text] [Related]
4. An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Liu P; Pan Z; Gu C; Cao X; Liu X; Zhang J; Xiao Z; Wang X; Guo H; Ju D; Deng SJ Front Immunol; 2020; 11():596908. PubMed ID: 33329588 [TBL] [Abstract][Full Text] [Related]
5. A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema. Lang DM Ann Allergy Asthma Immunol; 2014 Apr; 112(4):276-9. PubMed ID: 24589165 [No Abstract] [Full Text] [Related]
6. The application of phage display in allergy research: characterization of IgE, identification of allergens and development of novel therapeutics. Edwards MR; Collins AM; Ward RL Curr Pharm Biotechnol; 2001 Sep; 2(3):225-40. PubMed ID: 11530877 [TBL] [Abstract][Full Text] [Related]
7. [Progress in the study of allergic disease drugs targeting on IgE/FcepsilonRI signaling pathway]. Liu ZC; Shi HL; Zhang YF; Zhao LJ Yao Xue Xue Bao; 2011 Oct; 46(10):1161-6. PubMed ID: 22242444 [TBL] [Abstract][Full Text] [Related]
12. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology. Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583 [TBL] [Abstract][Full Text] [Related]
15. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases. D'Amato G; Oldani V; Donner CF Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a novel anti-IgE monoclonal antibody. Qian W; Zhang X; Li B; Zhang D; Tong Q; Chen L; Zheng L; Kou G; Wang H; Hou S; Guo Y Biochem Biophys Res Commun; 2010 May; 395(4):547-52. PubMed ID: 20394728 [TBL] [Abstract][Full Text] [Related]
17. Development of small molecules to target the IgE:FcεRI protein-protein interaction in allergies. Smith LD; Leatherbarrow RJ; Spivey AC Future Med Chem; 2013 Aug; 5(12):1423-35. PubMed ID: 23919552 [TBL] [Abstract][Full Text] [Related]
18. Increase in human basophils IgE-mediated stimulation by omalizumab: a role for membrane FcγRs? Chirumbolo S; Olivieri M J Allergy Clin Immunol; 2014 May; 133(5):1493-4. PubMed ID: 24642141 [No Abstract] [Full Text] [Related]
20. Structure/function studies on IgE as a basis for the development of rational IgE antagonists. Helm BA; Sayers I; Padlan EA; McKendrick JE; Spivey AC Allergy; 1998; 53(45 Suppl):77-82. PubMed ID: 9788713 [No Abstract] [Full Text] [Related] [Next] [New Search]